Application Sponsors
| ANDA 210152 | BIONPHARMA INC |  | 
Marketing Status
| Prescription | 001 | 
| Prescription | 002 | 
Application Products
| 001 | TABLET;ORAL | 2.5MG | 0 | APIXABAN | APIXABAN | 
| 002 | TABLET;ORAL | 5MG | 0 | APIXABAN | APIXABAN | 
FDA Submissions
| UNKNOWN;  | ORIG | 1 | AP | 2020-04-08 | STANDARD  | 
| LABELING; Labeling | SUPPL | 2 | AP | 2022-05-20 | STANDARD  | 
Submissions Property Types
TE Codes
| 001 | Prescription | AB | 
| 002 | Prescription | AB | 
CDER Filings
BIONPHARMA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210152
            [companyName] => BIONPHARMA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"APIXABAN","activeIngredients":"APIXABAN","strength":"2.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"APIXABAN","activeIngredients":"APIXABAN","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/08\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-04-08
        )
)